3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
21 04 2023
Historique:
received: 28 12 2022
accepted: 13 04 2023
medline: 25 4 2023
pubmed: 22 4 2023
entrez: 21 04 2023
Statut: epublish

Résumé

Ependymoma is a tumor of the brain or spinal cord. The two most common and aggressive molecular groups of ependymoma are the supratentorial ZFTA-fusion associated and the posterior fossa ependymoma group A. In both groups, tumors occur mainly in young children and frequently recur after treatment. Although molecular mechanisms underlying these diseases have recently been uncovered, they remain difficult to target and innovative therapeutic approaches are urgently needed. Here, we use genome-wide chromosome conformation capture (Hi-C), complemented with CTCF and H3K27ac ChIP-seq, as well as gene expression and DNA methylation analysis in primary and relapsed ependymoma tumors, to identify chromosomal conformations and regulatory mechanisms associated with aberrant gene expression. In particular, we observe the formation of new topologically associating domains ('neo-TADs') caused by structural variants, group-specific 3D chromatin loops, and the replacement of CTCF insulators by DNA hyper-methylation. Through inhibition experiments, we validate that genes implicated by these 3D genome conformations are essential for the survival of patient-derived ependymoma models in a group-specific manner. Thus, this study extends our ability to reveal tumor-dependency genes by 3D genome conformations even in tumors that lack targetable genetic alterations.

Identifiants

pubmed: 37085539
doi: 10.1038/s41467-023-38044-0
pii: 10.1038/s41467-023-38044-0
pmc: PMC10121654
doi:

Substances chimiques

Chromatin 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2300

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM074024
Pays : United States
Organisme : NIH HHS
ID : DP5 OD023071
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS130137
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA210004
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA184898
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA258406
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS116455
Pays : United States
Organisme : NLM NIH HHS
ID : T15 LM011271
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS120075
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA217885
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Genome Res. 2016 Feb;26(2):256-62
pubmed: 26631489
Cell Stem Cell. 2010 May 7;6(5):421-32
pubmed: 20452317
Nat Protoc. 2020 Mar;15(3):991-1012
pubmed: 31980751
Nucleic Acids Res. 2017 Sep 29;45(17):e152
pubmed: 28973466
Nat Cell Biol. 2020 May;22(5):603-615
pubmed: 32284543
Bioinformatics. 2012 Sep 15;28(18):i333-i339
pubmed: 22962449
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nature. 2014 Jun 26;510(7506):537-41
pubmed: 24847876
Cancer Discov. 2021 Nov;11(11):2764-2779
pubmed: 34373263
Neuro Oncol. 2019 Dec 17;21(12):1540-1551
pubmed: 31276586
Neuro Oncol. 2019 Jul 11;21(7):867-877
pubmed: 30943283
Int J Oncol. 2013 Aug;43(2):425-30
pubmed: 23708747
Nat Genet. 2018 Oct;50(10):1388-1398
pubmed: 30202056
Cell. 2020 Jun 11;181(6):1329-1345.e24
pubmed: 32445698
Cell Rep. 2019 Apr 16;27(3):971-986.e9
pubmed: 30995489
Oncol Rep. 2014 Jan;31(1):262-72
pubmed: 24173498
Nat Genet. 2022 Dec;54(12):1865-1880
pubmed: 36471070
Nature. 2012 Jan 04;481(7381):389-93
pubmed: 22217937
Nature. 2016 Jan 7;529(7584):110-4
pubmed: 26700815
Cell. 2014 Dec 18;159(7):1665-80
pubmed: 25497547
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Cancer Res. 2017 Sep 1;77(17):4652-4662
pubmed: 28667074
Acta Neuropathol. 2011 Nov;122(5):637-50
pubmed: 21863243
Nature. 2014 Feb 27;506(7489):445-50
pubmed: 24553142
Oncogene. 2015 Sep 10;34(37):4834-44
pubmed: 25486429
Cell. 2015 May 21;161(5):1012-1025
pubmed: 25959774
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
pubmed: 29126249
Bioinformatics. 2018 Jan 15;34(2):338-345
pubmed: 29048467
Acta Neuropathol. 2018 Aug;136(2):211-226
pubmed: 29909548
Cancer Cell. 2015 May 11;27(5):728-43
pubmed: 25965575
Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10544-9
pubmed: 21670270
Nucleic Acids Res. 2016 Apr 20;44(7):e70
pubmed: 26704975
Hum Mol Genet. 2018 Aug 1;27(R2):R228-R233
pubmed: 29767704
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Cancer Discov. 2021 Sep;11(9):2216-2229
pubmed: 33741711
Nat Genet. 2012 May 29;44(6):619-22
pubmed: 22641210
Nat Commun. 2016 Jan 22;7:10481
pubmed: 26795843
Nat Genet. 2020 Apr;52(4):388-400
pubmed: 32203470
Nature. 2020 Jul;583(7818):737-743
pubmed: 32728247
Cell Syst. 2016 Jul;3(1):99-101
pubmed: 27467250
Nat Protoc. 2021 Sep;16(9):4144-4176
pubmed: 34373652
PLoS One. 2015 Jun 25;10(6):e0131760
pubmed: 26111147
Acta Neuropathol. 2017 Nov;134(5):705-714
pubmed: 28733933
Genome Biol. 2008;9(9):R137
pubmed: 18798982
J Cancer. 2017 Aug 25;8(15):2992-3000
pubmed: 28928891
Nature. 2014 Feb 27;506(7489):451-5
pubmed: 24553141
Cell Rep. 2016 Nov 15;17(8):2042-2059
pubmed: 27851967
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Acta Neuropathol Commun. 2016 Aug 22;4(1):88
pubmed: 27550150
Nature. 2019 Nov;575(7781):229-233
pubmed: 31666694
BMC Bioinformatics. 2019 Jan 31;20(1):60
pubmed: 30704404
Prostate. 2014 May;74(5):488-96
pubmed: 24375374
Nature. 2012 Apr 11;485(7398):376-80
pubmed: 22495300
Science. 2018 Dec 14;362(6420):
pubmed: 30545851
Bioinformatics. 2018 Feb 15;34(4):672-674
pubmed: 29028898
Neuro Oncol. 2019 Jul 11;21(7):878-889
pubmed: 30923826
Nature. 2018 Jan 4;553(7686):101-105
pubmed: 29258295
Nat Rev Clin Oncol. 2011 Jun 28;8(9):540-9
pubmed: 21709698
F1000Res. 2015 Nov 20;4:1310
pubmed: 26835000
Genome Biol. 2015 Dec 01;16:259
pubmed: 26619908
Cancer Cell. 2011 Aug 16;20(2):143-57
pubmed: 21840481
Cancer Discov. 2021 Sep;11(9):2230-2247
pubmed: 33879448
Nat Commun. 2019 Sep 2;10(1):3914
pubmed: 31477715
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Mol Cancer Ther. 2016 Aug;15(8):1799-808
pubmed: 27207779
Nat Commun. 2019 Sep 12;10(1):4154
pubmed: 31515496
PLoS One. 2016 Dec 1;11(12):e0167417
pubmed: 27907167

Auteurs

Konstantin Okonechnikov (K)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.

Aylin Camgöz (A)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
National Center for Tumor Diseases (NCT): German Cancer Research Center (DKFZ) Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.

Owen Chapman (O)

Division of Genomics and Precision Medicine, Department of Medicine, University of California San Diego (UCSD), San Diego, USA.

Sameena Wani (S)

Division of Genomics and Precision Medicine, Department of Medicine, University of California San Diego (UCSD), San Diego, USA.

Donglim Esther Park (DE)

Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, La Jolla, CA, 92037, USA.
Sanford Consortium for Regenerative Medicine, 2880 Torrey Pines Scenic Drive, La Jolla, CA, 92037, USA.

Jens-Martin Hübner (JM)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.

Abhijit Chakraborty (A)

Centers for Cancer Immunotherapy and Autoimmunity, La Jolla Institute for Immunology, La Jolla, CA, USA.

Meghana Pagadala (M)

Division of Genomics and Precision Medicine, Department of Medicine, University of California San Diego (UCSD), San Diego, USA.

Rosalind Bump (R)

Peptide Biology Labs, Salk Institute for Biological Studies, La Jolla, CA, USA.

Sahaana Chandran (S)

Peptide Biology Labs, Salk Institute for Biological Studies, La Jolla, CA, USA.

Katerina Kraft (K)

Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA, USA.

Rocio Acuna-Hidalgo (R)

Max Planck Institute for Molecular Genetics, Berlin, Germany.
Institute for Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.

Derek Reid (D)

Arima Genomics, Inc, San Diego, CA, 92121, USA.

Kristin Sikkink (K)

Arima Genomics, Inc, San Diego, CA, 92121, USA.

Monika Mauermann (M)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.

Edwin F Juarez (EF)

Division of Genomics and Precision Medicine, Department of Medicine, University of California San Diego (UCSD), San Diego, USA.

Anne Jenseit (A)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.

James T Robinson (JT)

Division of Genomics and Precision Medicine, Department of Medicine, University of California San Diego (UCSD), San Diego, USA.

Kristian W Pajtler (KW)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.

Till Milde (T)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.
CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.

Natalie Jäger (N)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.

Petra Fiesel (P)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
CCU Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.

Ling Morgan (L)

Division of Genomics and Precision Medicine, Department of Medicine, University of California San Diego (UCSD), San Diego, USA.

Sunita Sridhar (S)

Division of Genomics and Precision Medicine, Department of Medicine, University of California San Diego (UCSD), San Diego, USA.

Nicole G Coufal (NG)

Sanford Consortium for Regenerative Medicine, 2880 Torrey Pines Scenic Drive, La Jolla, CA, 92037, USA.
Department of Pediatrics, University of California, San Diego, San Diego, CA, 92093, USA.

Michael Levy (M)

Neurosurgery, University of California San Diego - Rady Children's Hospital, San Diego, CA, 92123, USA.

Denise Malicki (D)

Pathology, University of California San Diego - Rady Children's Hospital, San Diego, CA, 92123, USA.

Charlotte Hobbs (C)

Rady Children's Institute for Genomic Medicine, San Diego, CA, 92123, USA.

Stephen Kingsmore (S)

Rady Children's Institute for Genomic Medicine, San Diego, CA, 92123, USA.

Shareef Nahas (S)

Rady Children's Institute for Genomic Medicine, San Diego, CA, 92123, USA.

Matija Snuderl (M)

Department of Pathology, NYU Langone Health, NYU Grossman School of Medicine, 550 First Ave, New York, NY, 10016, USA.
Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.

John Crawford (J)

Department of Neurosciences, University of California San Diego - Rady Children's Hospital, San Diego, CA, 92123, USA.

Robert J Wechsler-Reya (RJ)

Sanford Consortium for Regenerative Medicine, 2880 Torrey Pines Scenic Drive, La Jolla, CA, 92037, USA.
Department of Pediatrics, University of California, San Diego, San Diego, CA, 92093, USA.
Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Tom Belle Davidson (TB)

Division of Hematology-Oncology, Cancer and Blood Disease Institute and Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.

Jennifer Cotter (J)

Division of Hematology-Oncology, Cancer and Blood Disease Institute and Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.

George Michaiel (G)

Division of Hematology-Oncology, Cancer and Blood Disease Institute and Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.

Gudrun Fleischhack (G)

German Cancer Consortium (DKTK), West German Cancer Center, Pediatrics III, University Hospital Essen, Essen, Germany.

Stefan Mundlos (S)

Max Planck Institute for Molecular Genetics, Berlin, Germany.

Anthony Schmitt (A)

Arima Genomics, Inc, San Diego, CA, 92121, USA.

Hannah Carter (H)

Division of Genomics and Precision Medicine, Department of Medicine, University of California San Diego (UCSD), San Diego, USA.

Kulandaimanuvel Antony Michealraj (KA)

Division of Neurosurgery, Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, University of Toronto, Toronto, ONT, Canada.

Sachin A Kumar (SA)

Division of Neurosurgery, Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, University of Toronto, Toronto, ONT, Canada.

Michael D Taylor (MD)

Division of Neurosurgery, Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, University of Toronto, Toronto, ONT, Canada.

Jeremy Rich (J)

Division of Regenerative Medicine, Department of Medicine, University of California, San Diego, La Jolla, CA, 92037, USA.
Sanford Consortium for Regenerative Medicine, 2880 Torrey Pines Scenic Drive, La Jolla, CA, 92037, USA.
Department of Neurosciences, School of Medicine, University of California San Diego, La Jolla, CA, 92037, USA.

Frank Buchholz (F)

National Center for Tumor Diseases (NCT): German Cancer Research Center (DKFZ) Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
Medical Systems Biology, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, 01307, Dresden, Germany.
German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site Dresden, Dresden, Germany.

Jill P Mesirov (JP)

Division of Genomics and Precision Medicine, Department of Medicine, University of California San Diego (UCSD), San Diego, USA.
Moores Cancer Center, University of California San Diego (UCSD), La Jolla, CA, USA.

Stefan M Pfister (SM)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.

Ferhat Ay (F)

Centers for Cancer Immunotherapy and Autoimmunity, La Jolla Institute for Immunology, La Jolla, CA, USA.
Department of Pediatrics, University of California, San Diego, San Diego, CA, 92093, USA.

Jesse R Dixon (JR)

Peptide Biology Labs, Salk Institute for Biological Studies, La Jolla, CA, USA.

Marcel Kool (M)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Lukas Chavez (L)

Division of Genomics and Precision Medicine, Department of Medicine, University of California San Diego (UCSD), San Diego, USA. lukaschavez@health.ucsd.edu.
Rady Children's Institute for Genomic Medicine, San Diego, CA, 92123, USA. lukaschavez@health.ucsd.edu.
Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. lukaschavez@health.ucsd.edu.
Moores Cancer Center, University of California San Diego (UCSD), La Jolla, CA, USA. lukaschavez@health.ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH